| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | D015451 | 25 associated lipids |
| Diabetic Angiopathies | D003925 | 20 associated lipids |
| Polycythemia Vera | D011087 | 13 associated lipids |
| Mucocutaneous Lymph Node Syndrome | D009080 | 9 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Rheumatic Diseases | D012216 | 7 associated lipids |
| Cardiomyopathies | D009202 | 10 associated lipids |
| Disease Susceptibility | D004198 | 12 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mogelvang R et al. | Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. | 2012 | Am. J. Cardiol. | pmid:22100028 |
| Chung E and Rylander MN | Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. | 2012 | Cell Stress Chaperones | pmid:22116637 |
| Koch FP et al. | Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. | 2012 | Clin Oral Investig | pmid:20938793 |
| Li J et al. | Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. | 2012 | J Biomech | pmid:22119108 |
| Tanaka M et al. | Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. | 2012 | Bone Marrow Transplant. | pmid:22120987 |
| Funck-Brentano T et al. | Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. | 2012 | PLoS ONE | pmid:22432033 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Rojano-MejÃa D et al. | TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. | 2012 | Maturitas | pmid:22079369 |
| Ueland T et al. | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. | 2012 | Curr Heart Fail Rep | pmid:22453763 |
| Bogliolo L et al. | Biomarkers and prognostic stratification in psoriatic arthritis. | 2012 | Reumatismo | pmid:22690385 |
| Olesen M et al. | No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. | 2012 | Mol. Cell. Endocrinol. | pmid:22698523 |
| Cvija H et al. | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. | 2012 | Inflammation | pmid:22699680 |
| Liu L et al. | Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. | 2012 | J Endod | pmid:22703658 |
| Kühn MC et al. | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | 2012 | Mol. Cell. Endocrinol. | pmid:22040599 |
| Pineda B et al. | Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. | 2012 | Menopause | pmid:22067277 |
| Chuang FH et al. | Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. | 2012 | J. Oral Pathol. Med. | pmid:21793936 |
| Rodriguez-Lorenzo LM et al. | Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. | 2012 | J Tissue Eng Regen Med | pmid:21800433 |
| Duarte PM et al. | Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. | 2012 | J. Periodontol. | pmid:21859322 |
| Gimenez-Maitre A et al. | Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. | 2012 | Eur. Respir. J. | pmid:22379154 |
| Mao X et al. | Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. | 2012 | Inflammation | pmid:22391745 |
| Kim H et al. | Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. | 2012 | Arch. Gynecol. Obstet. | pmid:22392486 |
| Liu S et al. | Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. | 2012 | Hum. Cell | pmid:22399266 |
| Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
| Zupan J et al. | The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. | 2012 | J. Biomed. Sci. | pmid:22380539 |
| Chai YC et al. | Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. | 2012 | Biomaterials | pmid:22381474 |
| Hudson JB et al. | Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. | 2012 | Calcif. Tissue Int. | pmid:22382900 |
| Singh DK et al. | Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. | 2012 | Diabetes Res. Clin. Pract. | pmid:22386825 |
| Jia P et al. | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. | 2012 | Eur. J. Pharmacol. | pmid:22387856 |
| Eleftheriadis T et al. | Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. | 2012 | Iran J Kidney Dis | pmid:22388612 |
| Nonaka CF et al. | Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. | 2012 | Arch. Oral Biol. | pmid:21871606 |
| Zheleznyak A et al. | Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. | 2012 | Mol Imaging Biol | pmid:21853370 |
| Renno AC et al. | Ultrasound therapy modulates osteocalcin expression during bone repair in rats. | 2012 | Ultrasonics | pmid:21820693 |
| Dorota DK et al. | The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. | 2012 | Hypertens Pregnancy | pmid:20822429 |
| Bergström I et al. | Physical training increases osteoprotegerin in postmenopausal women. | 2012 | J. Bone Miner. Metab. | pmid:21823052 |
| Mayahara K et al. | Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). | 2012 | Arch. Oral Biol. | pmid:22884709 |
| Hosbond SE et al. | Osteoprotegerin as a marker of atherosclerosis: a systematic update. | 2012 | Scand. Cardiovasc. J. | pmid:22506827 |
| Wang JQ et al. | [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. | 2012 | Zhongguo Gu Shang | pmid:23427595 |
| Li YF et al. | The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. | 2012 | Osteoporos Int | pmid:21892678 |
| Singh PP et al. | Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22561018 |
| Ohe JY et al. | Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. | 2012 | Clin Oral Investig | pmid:21938481 |
| Ma D et al. | Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. | 2012 | J. Proteome Res. | pmid:22616666 |
| Kim EC et al. | Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. | 2012 | J Endod | pmid:22595110 |
| da Silva RA et al. | Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. | 2012 | J Endod | pmid:22595116 |
| Chen WH et al. | Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. | 2012 | Chin J Integr Med | pmid:22549392 |
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Wang YD et al. | Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. | 2012 | Horm. Metab. Res. | pmid:22556124 |
| Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
| Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
| Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
| Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
| Schweikle E et al. | Osteoprotegerin positively regulates hematopoietic progenitor cells. | 2012 | Curr Stem Cell Res Ther | pmid:22023625 |
| GarcÃa-MartÃn A et al. | [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. | 2012 | Med Clin (Barc) | pmid:22024564 |
| Zijlstra WP et al. | Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. | 2012 | J. Orthop. Res. | pmid:22025323 |
| Zhao N et al. | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. | 2012 | Orthod Craniofac Res | pmid:22264323 |
| Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
| Martin CK et al. | Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. | 2012 | Oral Oncol. | pmid:22265717 |
| Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
| Garlet GP et al. | Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. | 2012 | J Endod | pmid:22244633 |
| Liu T et al. | [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230665 |
| Li L et al. | [Progress of osteogenic effect of strontium and its application in orthopaedics]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230680 |
| Vik A et al. | Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. | 2012 | Thromb. Res. | pmid:22909822 |
| Dong W et al. | [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. | 2012 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:23268391 |
| Feng Y et al. | AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. | 2012 | Chin. Med. J. | pmid:22964327 |
| Pedersen S et al. | Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. | 2012 | Cardiology | pmid:22964478 |
| Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
| Cauley JA | Commentary: A single biomarker in a complex metabolic pathway. | 2012 | Int J Epidemiol | pmid:22933649 |
| Deuell KA et al. | RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. | 2012 | J. Vasc. Res. | pmid:22948607 |
| Li F et al. | Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. | 2012 | Fitoterapia | pmid:22951288 |
| Buckle CH et al. | Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. | 2012 | PLoS ONE | pmid:22952578 |
| Zheng CM et al. | Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. | 2012 | Tohoku J. Exp. Med. | pmid:22156488 |
| Said F et al. | The effect of etidronate on the periodontium of ovariectomized rats. | 2012 | J. Periodontol. | pmid:22166164 |
| Guo D et al. | Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. | 2012 | Mol. Cell. Biochem. | pmid:22167620 |
| Svensson M et al. | Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. | 2012 | Nephrol. Dial. Transplant. | pmid:22172725 |
| Kraus D et al. | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. | 2012 | Clin Oral Investig | pmid:22186940 |
| Zhao N et al. | Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22196183 |
| Chen J et al. | OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. | 2012 | Rheumatol. Int. | pmid:22210270 |
| Giannopoulou C et al. | Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. | 2012 | Acta Odontol. Scand. | pmid:22214279 |
| Bloch SL and Sørensen MS | Otosclerosis: a perilabyrinthine threshold phenomenon. | 2012 | Acta Otolaryngol. | pmid:22217131 |
| Wang S and Liu YS | [Advance on arterial calcification]. | 2012 | Sheng Li Ke Xue Jin Zhan | pmid:23189619 |
| Pecchi E et al. | A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. | 2012 | Osteoarthr. Cartil. | pmid:22179028 |
| Upton AR et al. | The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. | 2012 | Rheumatol. Int. | pmid:21259010 |
| Bilgin E et al. | Markers of bone metastases in breast and lung cancers. | 2012 | Asian Pac. J. Cancer Prev. | pmid:23167338 |
| Luo ZR and Xie QJ | [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. | 2012 | Zhongguo Wei Zhong Bing Ji Jiu Yi Xue | pmid:23168201 |
| Li YL and Wang H | [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. | 2012 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:22989431 |
| Tyagi AM et al. | Formononetin reverses established osteopenia in adult ovariectomized rats. | 2012 | Menopause | pmid:22781783 |
| Kim IS et al. | Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. | 2012 | J. Dent. Res. | pmid:23086742 |
| Xu Y et al. | [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803436 |
| Zhu XF et al. | [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803437 |
| Nyrnes A et al. | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. | 2012 | Gend Med | pmid:23046763 |
| Davenport C et al. | The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. | 2012 | Eur. J. Clin. Invest. | pmid:22803952 |
| Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
| Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
| Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
| Kleyer A et al. | Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. | 2012 | J. Bone Miner. Res. | pmid:22806960 |
| Giaginis C et al. | Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. | 2012 | Med. Sci. Monit. | pmid:23018352 |
| Wang C et al. | Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. | 2012 | J. Bone Miner. Res. | pmid:22807154 |
| Poerschke RL et al. | Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. | 2012 | J. Biochem. Mol. Toxicol. | pmid:22807314 |
| Chandran V | Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. | 2012 | J Rheumatol Suppl | pmid:22751596 |
| Melchiorre D et al. | RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. | 2012 | J. Rheumatol. | pmid:22753650 |
| Belibasakis GN and Bostanci N | The RANKL-OPG system in clinical periodontology. | 2012 | J. Clin. Periodontol. | pmid:22092994 |